Of note, in vitro studies using B cells from MS patients demonstrate the ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) expressing B cells to efficiently enhance myeloid cell pro-inflammatory responses in a GM-CSF dependent manner (115). Here, CSF2 is linked to myeloid sarcoma.